SpaceX’s million-satellite proposal points to an ambitious next chapter for artificial intelligence, with opportunities extending from advanced chips to spacecraft and solar power systems.
Artificial intelligence has spent the past several years moving into the cloud. Elon Musk would like many to…
The planned ANT listing offers many a direct stake in the enterprise AI boom, with Amazon and Alphabet already deeply invested. The opportunity is enormous. So is the cost of admission.
October 26, 2026
Anthropic has given Wall Street a new way…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
A postponed listing clouds the financing picture, but the investment case for AI memory, storage and sovereign infrastructure extends well beyond the IPO calendar.
Wall Street has temporarily misplaced its enthusiasm for memory stocks. Artificial intelligence, inconveniently for the bears, still needs…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
A $180 million expansion in Florida, a richer income opportunity for savers and an airline chief’s inheritance-tax proposal reveal where the next chapter of American wealth could unfold.
America’s retirement economy is offering investors an intriguing combination: more potential customers, substantial demand…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
A substantial takeover premium highlights the value of differentiated medicines, while Serina Therapeutics and Eupraxia Pharmaceuticals approach clinical milestones of their own.
October 19, 2026
Biotechnology investors received a rather emphatic reminder Monday that pharmaceutical innovation can still command a premium, even…
